FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Sodium Chloride Injection Recall

Sodium Chloride Injection, USP, 0

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Jul 31, 2013
Recall ID
D-813-2013
Check your lot numberHow we source this data

Summary

Hospira recalled Sodium Chloride Injection starting Jun 27, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-813-2013 on Jul 31, 2013. Reason: Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of the plastic vial. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of the plastic vial.

Product description

Sodium Chloride Injection, USP, 0.9%, 20 mL Single-dose Fliptop Plastic Vial, packaged in 25 vial Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4888-20.

Lot numbers, UPCs & expiration codes

Lot #: 15-058-DK*, Exp 1MAR2014; note the * may be followed by 01

Where it was sold

Nationwide and Guam

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-813-2013
Classification
Class II
Status
Terminated
Recall initiated
Jun 27, 2013
FDA report date
Jul 31, 2013
Quantity
268,700 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-813-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
65731
Address
275 N Field Dr
Code information
Lot #: 15-058-DK*, Exp 1MAR2014; note the * may be followed by 01
Postal code
60045-2579
Report date
Jul 31, 2013
Product type
Drugs
Recall number
D-813-2013
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
268,700 vials
Termination date
Jun 4, 2015
Reason for recall
Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of the plastic vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sodium Chloride Injection, USP, 0.9%, 20 mL Single-dose Fliptop Plastic Vial, packaged in 25 vial Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-4888-20.
Distribution pattern
Nationwide and Guam
Recall initiation date
Jun 27, 2013
Initial firm notification
Letter
Center classification date
Jul 22, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-813-2013, published Jul 31, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls